P

Inventor

JAGASIA RAVI

DE24 patents
⚠️ This page may combine multiple inventors who share the name “JAGASIA RAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

20 patents
US11852627B2Dec 26, 2023

Oligonucleotides for inducing paternal UBE3A expression

HOFFMANN LA ROCHE3 citations82
US11320421B2May 3, 2022

Oligonucleotides for inducing paternal UBE3A expression

HOFFMANN LA ROCHE3 citations82
US12259380B2Mar 25, 2025

Oligonucleotides for inducing paternal UBE3A expression

HOFFMANN LA ROCHE2 citations73
US12566172B2Mar 3, 2026

Oligonucleotides for inducing paternal UBE3A expression

HOFFMANN LA ROCHE0 citations61
US12104153B2Oct 1, 2024

Antisense oligonucleotide for targeting progranulin

HOFFMANN LA ROCHE0 citations53
US12360123B2Jul 15, 2025

E3 ubiquitin ligase (UBE3A) protein targets

HOFFMANN LA ROCHE0 citations52
US9688675B2Jun 27, 2017

1,7-naphthyridine derivatives

HOFFMANN LA ROCHE0 citations52
US9586966B2Mar 7, 2017

Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-one

HOFFMANN LA ROCHE0 citations52
US9464049B2Oct 11, 2016

Indole-carboxamides

HOFFMANN LA ROCHE0 citations52
US9440962B2Sep 13, 2016

Benzisoxazoles

HOFFMANN LA ROCHE0 citations52
US9365550B2Jun 14, 2016

Benzimidazoles as CNS active agents

HOFFMANN LA ROCHE1 citations52
US9315502B2Apr 19, 2016

Imidazopyridine derivatives

HOFFMANN LA ROCHE0 citations52
US12203071B2Jan 21, 2025

Oligonucleotide agonists targeting progranulin

HOFFMANN LA ROCHE0 citations51
US12084657B2Sep 10, 2024

Oligonucleotides targeting RNA binding protein sites

HOFFMANN LA ROCHE0 citations50
US9297025B2Mar 29, 2016

Conversion of somatic cells to induced reprogrammed neural stem cells (irNSCs)

HOFFMANN LA ROCHE0 citations46
US9714239B2Jul 25, 2017

N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders

HOFFMANN LA ROCHE0 citations42
US9670206B2Jun 6, 2017

Pyrido[4,3-B]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders

HOFFMANN LA ROCHE0 citations42
US9657014B2May 23, 2017

Substituted 1,6-naphthyridines

HOFFMANN LA ROCHE0 citations41
US9586903B2Mar 7, 2017

Isoquinoline derivatives

HOFFMANN LA ROCHE0 citations41
US9284321B2Mar 15, 2016

Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one

HOFFMANN LA ROCHE0 citations41

ROCHE INNOVATION CT COPENHAGEN AS

3 patents

HOFFMANN LA ROCHE INC

1 patent